Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06936943 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

ONO-4538 Study in Patients With Richter's Transformation

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Changed Sponsor changed: Ono Pharmaceutical Co. Ltd to Ono Pharmaceutical Co., Ltd.
  2. Study sites: 9 to 10v5
  3. Study sites: 8 to 9 Start date changed from estimate of Sep 2025 to Nov 19, 2025v4 Show 1 more changeShow less
    • Start date changed from estimate of Sep 2025 to Nov 19, 2025
  4. Study sites: 3 to 8 Eligibility criteria expanded, about 13 wordsv3 Show 1 more changeShow less
    • Eligibility criteria expanded, about 13 words

    See this version in full on ClinicalTrials.gov ↗

  5. Trial status: Not Yet Recruiting to Recruiting Start date: Apr 21, 2025 to Sep 2025 · Study sites: 2 to 3 · Completion date: Mar 31, 2030 to Jul 31, 2030v2 Show 3 more changesShow less
    • Start date: Apr 21, 2025 to Sep 2025
    • Study sites: 2 to 3
    • Completion date: Mar 31, 2030 to Jul 31, 2030
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Investigate the efficacy and safety of ONO-4538 in patients with Richter's transformation
Trial Details
NCT Number NCT06936943
Lead Sponsor Ono Pharmaceutical Co., Ltd.
Conditions Richter's Transformation
Enrollment 14 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov